PDS Biotechnology Corp (PDSB) insider trading

Every open-market stock purchase and sale by PDS Biotechnology Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Stephen C. Glover (Insider), $23K, 20 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.24 on Oct 21, 2026.

Recent PDSB insider trades

DateInsiderTradeValue
Oct 18, 2026Bruce Wendel (Insider)Bought (not open market)—
Oct 18, 2026John Andrew Dawson (Insider)Bought (not open market)—
Oct 18, 2026Deborah Ramsdell (Insider)Bought (not open market)—
Jan 12, 2026Kamil Ali-Jackson (Insider)Bought (not open market)—
Jan 12, 2026Lars Boesgaard (CFO)Bought (not open market)—
Jan 12, 2026Spencer D. Brown (VP)Bought (not open market)—
Jan 12, 2026Ilian Iliev (Insider)Bought (not open market)—
Jan 12, 2026Gregory Gene Freitag (Insider)Bought (not open market)—
Jan 12, 2026Frank Bedu-Addo (CEO)Bought (not open market)—
Jan 12, 2026Otis W Brawley (Insider)Bought (not open market)—
Jan 12, 2026Gregory Conn (C-suite exec)Bought (not open market)—
Jan 12, 2026Stephen C. Glover (Insider)Bought (not open market)—
Jan 12, 2026Kirk V. Shepard (C-suite exec)Bought (not open market)—
Jan 12, 2026Stephan Toutain (COO)Bought (not open market)—

Who's trading PDSB

Get free alerts when an insider at PDS Biotechnology Corp files a new trade →